Top compounds associated with response to ZBTB25


Feature Type Standardized
Nominal ANOVA
mRNA TG-101348 GDSC1000 pan-cancer AAC -0.082 0.005
mRNA Rapamycin GDSC1000 pan-cancer AAC 0.15 0.005
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.005
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.16 0.005
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.11 0.005
mRNA etoposide CTRPv2 pan-cancer AAC 0.087 0.005
mRNA prima-1 CTRPv2 pan-cancer AAC 0.09 0.006
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.006
mRNA masitinib GDSC1000 pan-cancer AAC -0.091 0.006
Download CSV